143 Mesothelin (MSLN) targeting allogeneic CAR T cells engineered to overcome tumor immunosuppressive microenvironment

• Agnes Gouble,
• Roman Galetto,
• Cécile Schiffer-Mannioui,
• Sophie Leduc,
• Isabelle Chion-Sotinel,
• Diane le Clerre,
• Valérie Guyot,
• Marco Rotondi

Affiliations

Agnes Gouble

Aff1 Cellectis Therapeutics Paris France

Roman Galetto

Aff1 Cellectis Therapeutics Paris France

Cécile Schiffer-Mannioui

Aff1 Cellectis Therapeutics Paris France

Sophie Leduc

Cellectis SA, Paris, France

Isabelle Chion-Sotinel

Cellectis SA, Paris, France

Diane le Clerre

Cellectis SA, Paris, France

Valérie Guyot

Cellectis SA, Paris, France

Marco Rotondi

Cellectis SA, Paris, France